Skip to content

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07001423
Acronym
COFFEE
Enrollment
400
Registered
2025-06-03
Start date
2025-10-09
Completion date
2032-08-31
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystectomy, Laparoscopic, Choledocholithiasis, Cholelithiasis

Brief summary

The goal of this study is to compare safety and efficacy of laparoscopic cholecystectomy versus wait-and-see policy after endoscopic removal of common bile duct stones in elderly. The primary endpoint is a composite outcome: Death or major postoperative complications or recurrent biliary disease within 1 year after randomization.

Detailed description

Elderly patients with common bile duct stones are asked to participate this randomized trial after successful endoscopic removal of common bile duct stones. The hypothesis of the study is that wait-and-see policy is non-inferior to laparoscopic cholecystectomy. Four hundred patients are randomized 1:1 to either laparoscopic cholecystectomy group or wait-and see group. Cholecystectomy is done on the same admission or within two weeks after randomization. One interim analysis is planned for the trial after 100 randomized patients to assess safety. The trial is terminated if there is a statistically significant difference in primary outcome with p\<0.001 (chi-square test) between the study arms.

Interventions

PROCEDURELaparoscopic cholecystectomy

Laparoscopic cholecystectomy within 2 weeks after endoscopic removal of common bile duct stone

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP) * Age \>= 80 years or age 75-79 years with a Charlson Comorbidity index \>=2 * gallbladder in situ

Exclusion criteria

* Acute Cholecystitis * Biliary Pancreatitis * Severe or moderately severe post-ERCP pancreatitis * Chronic pancreatitis * Bile duct pathology * Widespread malignancy * Unable to give consent

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with composite outcome of death, major complication or recurrent biliary eventFrom randomization to 1 yearThe primary outcome is a composite outcome including death within 1 year after randomization, the occurrence of major complications within 30 days from surgery and recurrent biliary event requiring hospitalization. within 1 year after randomization. A recurrent biliary event refers to cholecystitis, pancreatitis, cholangitis, or bile duct stones. Major complications were defined as infectious, cardiovascular and pulmonary complications, and surgical complication (Clavien-Dindo grade III or higher)

Secondary

MeasureTime frameDescription
Number of good daysFrom randomization to 1 yearNumber of days alive and out of hospital
EQ VAS valueat 30 days, 180 days and 365 days after randomizationQuality of life is measured using EuroQOL EQ-5D-5L instrument, EQ VAS values are compared. 0 represents the worst health a person can imagine and 100 represents the the best health a person can imagine. EQ-5D-5L dimension responses are reported as a descriptive data
SurvivalFrom randomization to 1 yearSurvival is measured using Kaplan-Meier analysis
Number of patients with major complicationsFrom randomization to 1 yearNumber of patients with major complications defined as infectious, cardiovascular, and pulmonary complications, and surgical complication (Clavien-Dindo grade III or higher)
Number of patients with recurrent biliary eventFrom randomization to 1 yearNumber of patients with recurrent biliary event (cholecystitis, pancreatitis, cholangitis, or symptomatic bile duct stones)
Composite outcome of death or occurrence of major complications or recurrent biliary event requiring hospitalizationFrom randomization to 2 yearsThe same as primary outcome, but after 2 years follow-up
Number of patients with uncomplicated biliary pain or post cholecystectomy painAt 30, 180 and 365 days after randomizationUncomplicated biliary pain/ post cholecystectomy pain. Specific 5 criteria of biliary pain include : 1. severe pain attacks, 2. lasting 15 to 30 minutes or longer, 3. location in epigastrium or right upper quadrant, 4. pain radiating to the back, 5. a positive pain response to simple analgesics
Healthcare costsFrom randomization to 1 yearHealthcare costs related to bile stones; including laboratory tests, imaging (ultra sound, computer tomography, magnetic resonance imaging), procedures (Endoscopic Retrograde Cholangio Pancreatography (ERCP), laparoscopic cholecystectomy), emergency visits and hospital days.

Countries

Finland

Contacts

CONTACTPanu Mentula, MD, PhD
panu.mentula@hus.fi+358504270183
CONTACTPäivi Siironen, MD, PhD
paivi.siironen@hus.fi+358504271343
PRINCIPAL_INVESTIGATORPanu Mentula, MD, PhD

Helsinki University Central Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026